Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Hemophilia A or B

PHASE3TerminatedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 4, 2021

Primary Completion Date

November 15, 2021

Study Completion Date

December 1, 2021

Conditions
Hemophilia A With InhibitorHemophilia B With Inhibitor
Interventions
BIOLOGICAL

MarzAA

A cross over design to assess the efficacy of a dosing regimen of 60 µg/kg of MarzAA compared with standard of care for the treatment of bleeding episodes.

Trial Locations (43)

20007

Lombardi Comprehensive Cancer Center, Washington D.C.

85016

Phoenix Children's Hospital, Phoenix

Unknown

Hematology Center after Prof. R. Yeolyan, Yerevan

"JSC K.Eristavi National Center of Experimental and Clinical Surgery", Tbilisi

Magyar Honvédség Egészségügyi Központ, Országos Haemophilia Központ, Budapest

Nirmal Hospital, Gujrāt

K.L.E.S Dr. Prabhakar Kore Hospital and Medical Research Centre, Kārnād

Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow

K.J Somaiya Hospital and Research Centre, Mumbai

MCGM - Comprehensive Thalassemia Care, Pediatric Hematology-Oncology & BMT Centre, Mumbai

Sahyadri Specialty Hospital, Mumbai

Grant Medical Foundation, Ruby Hall Clinic, Pune

All India Institute of Medical Sciences, Rishikesh, Rishikesh

Azienda Ospedaliero-Universitaria Careggi, Florence

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan

Azienda Ospedaliera Universitaria Federico II, Napoli

Citta della Salute e della Scienza di Torino - Ospedale le Molinette, Torino

Hospital Ampang, Ampang

Raja Perempuan Zainab II Hospital, Kota Bharu

Queen Elizabeth Hospital Malaysia, Kota Kinabalu

Hospital Tunku Azizah Kuala Lumpur, Kuala Lumpur

Tuanku Ja'afar Hospital, Seremban, Sungai Petani

Instituto de Investigaciones Aplicada a la Neurociencia A.C., Durango

Instituto Nacional de Pediatria, Mexico City

Investigación e Innovación en Medicina Traslacional S.A.P.I. de C.V., Mexico City

Korczowski Bartosz, Gabinet Lekarski, Rzeszów

Kirov Research Institute of Hematology and Blood Transfusion, Kirov

Medis, Llc, Nizhny Novgorod

Haemophilia Comprehensive Care Centre, Johannesburg

Hospital Universitario Vall d'Hebron, Barcelona

Hospital de Malaga, Málaga

Changhua Christian Hospital (CCH), Changhua

Taichung Veterans General Hospital, Taichung

Akdeniz University Medical Faculty Hospital, Antalya

Istanbul University Faculty of Medicine, Istanbul

Ege University Medical Faculty, Izmir

Özel Acibadem Adana Hastanesi, Seyhan

"Cherkasy Regional Oncological Dispensary of Cherkasy Regional Council, Regional Treatment and Diagnostic Center of Hematology", Cherkasy

"Kyiv City Clinical Hospital #9 of Executive Body of Kyiv City Council (Kyiv City State Administration), City Scientific-Practical Centre of Diagnostics and Treatment", Kyiv

"Institute of Blood Pathology and Transfusion Medicine of National Academy of Medical Sciences of Ukraine, Haematology Department", Lviv

Queen Elizabeth Hospital Birmingham, Birmingham

Royal Liverpool University Hospital, Liverpool

University Hospital Southampton NHS Foundation Trust, Southampton

Sponsors
All Listed Sponsors
lead

Catalyst Biosciences

INDUSTRY